Skip to main content
Top
Literature
2.
go back to reference Asaka M, Kato M, Sugiyama T, et al. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. J Gastroenterol. 2003;38:339–347.CrossRef Asaka M, Kato M, Sugiyama T, et al. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. J Gastroenterol. 2003;38:339–347.CrossRef
3.
go back to reference Ponzetto A, Pellicano R, Palmas F, Demarchi B, Rizzetto M. Cigarette smokers and non smokers suffer of duodenal ulcer relapse rarely after cure of Helicobacter pylori infection. Eur J Internal Med. 1997;8:131–133. Ponzetto A, Pellicano R, Palmas F, Demarchi B, Rizzetto M. Cigarette smokers and non smokers suffer of duodenal ulcer relapse rarely after cure of Helicobacter pylori infection. Eur J Internal Med. 1997;8:131–133.
4.
go back to reference Capurso G, Annibale B, Osborn J, et al. Occurrence and relapse of bleeding from duodenal ulcer: respective roles of acid secretion and Helicobacter pylori infection. Aliment Pharmacol Ther. 2001;15:821–829.CrossRef Capurso G, Annibale B, Osborn J, et al. Occurrence and relapse of bleeding from duodenal ulcer: respective roles of acid secretion and Helicobacter pylori infection. Aliment Pharmacol Ther. 2001;15:821–829.CrossRef
5.
go back to reference Malfertheiner P, Megraud F, O’Morain CA, et al. Management of Helicobacter pylori infection—the Maastricht V/Florence consensus report. Gut. 2017;66:6–30.CrossRef Malfertheiner P, Megraud F, O’Morain CA, et al. Management of Helicobacter pylori infection—the Maastricht V/Florence consensus report. Gut. 2017;66:6–30.CrossRef
6.
go back to reference Takatori Y, Kato M, Sunata Y, et al. The role of history of gastro-duodenal ulcer in patients with upper gastrointestinal bleeding. Dig Dis. 2018;36:177–181.CrossRef Takatori Y, Kato M, Sunata Y, et al. The role of history of gastro-duodenal ulcer in patients with upper gastrointestinal bleeding. Dig Dis. 2018;36:177–181.CrossRef
7.
go back to reference Tang Y, Shen J, Zhang F, Zhou X, Tang Z, You T. Scoring systems used to predict mortality in patients with acute upper gastrointestinal bleeding in the ED. Am J Emerg Med. 2018;36:27–32.CrossRef Tang Y, Shen J, Zhang F, Zhou X, Tang Z, You T. Scoring systems used to predict mortality in patients with acute upper gastrointestinal bleeding in the ED. Am J Emerg Med. 2018;36:27–32.CrossRef
8.
go back to reference Choe JW, Kim SY, Hyun JJ, et al. Is the AIMS 65 score useful in predicting clinical outcomes in korean patients with variceal and nonvariceal upper gastrointestinal bleeding? Gut Liver. 2017;11:813–820.CrossRef Choe JW, Kim SY, Hyun JJ, et al. Is the AIMS 65 score useful in predicting clinical outcomes in korean patients with variceal and nonvariceal upper gastrointestinal bleeding? Gut Liver. 2017;11:813–820.CrossRef
10.
go back to reference Schilling D, Demel A, Nusse T, Weidmann E, Riemann JF. Helicobacter pylori infection does not affect the early rebleeding rate in patients with peptic ulcer bleeding after successful endoscopic hemostasis: a prospective single-center trial. Endoscopy. 2003;35:393–396.CrossRef Schilling D, Demel A, Nusse T, Weidmann E, Riemann JF. Helicobacter pylori infection does not affect the early rebleeding rate in patients with peptic ulcer bleeding after successful endoscopic hemostasis: a prospective single-center trial. Endoscopy. 2003;35:393–396.CrossRef
11.
go back to reference Park SJ, Park H, Lee YC, et al. Effect of scheduled second-look endoscopy on peptic ulcer bleeding: a prospective randomized multicenter trial. Gastrointest Endosc. 2018;87:457–465.CrossRef Park SJ, Park H, Lee YC, et al. Effect of scheduled second-look endoscopy on peptic ulcer bleeding: a prospective randomized multicenter trial. Gastrointest Endosc. 2018;87:457–465.CrossRef
12.
go back to reference Gisbert JP, Khorrami S, Carballo F, Calvet X, Gene E, Dominguez-Munoz JE. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. Cochrane Database Syst Rev. 2004:CD004062. Gisbert JP, Khorrami S, Carballo F, Calvet X, Gene E, Dominguez-Munoz JE. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. Cochrane Database Syst Rev. 2004:CD004062.
13.
go back to reference Wu CY, Wu MS, Kuo KN, Wang CB, Chen YJ, Lin JT. Long-term peptic ulcer rebleeding risk estimation in patients undergoing haemodialysis: a 10-year nationwide cohort study. Gut. 2011;60:1038–1042.CrossRef Wu CY, Wu MS, Kuo KN, Wang CB, Chen YJ, Lin JT. Long-term peptic ulcer rebleeding risk estimation in patients undergoing haemodialysis: a 10-year nationwide cohort study. Gut. 2011;60:1038–1042.CrossRef
14.
go back to reference Wong GL, Wong VW, Chan Y, et al. High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Gastroenterology. 2009;137:525–531.CrossRef Wong GL, Wong VW, Chan Y, et al. High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Gastroenterology. 2009;137:525–531.CrossRef
Metadata
Title
Risk of Rebleeding After Hemostasis for Peptic Ulcer
Authors
Antonio Ponzetto
John Holton
Publication date
01-01-2019
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2019
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5375-y

Other articles of this Issue 1/2019

Digestive Diseases and Sciences 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.